Addition of docetaxel to the cyclophosphamide/thiotepa/carboplatin regimen for autologous stem cell transplantation: A dose-escalation study of docetaxel for breast cancer.

被引：0
|
作者：
Kato, K [1 ]
Ohno, Y [1 ]
Miyoshi, T [1 ]
Mitsuyama, S [1 ]
Ohkubo, H [1 ]
机构：
[1] Kitakyushu Municipal Med Ctr, Fukuoka, Japan
来源：
BLOOD | 1998年 / 92卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4579
引用
收藏
页码：367B / 367B
页数：1
相关论文
共 50 条
  • [31] Double high-dose chemotherapy with adriamycin, paclitaxel, cyclophosphamide, and thiotepa followed by autologous peripheral blood stem cell transplantation in women with metastatic breast cancer
    Herbert G. Sayer
    Kristina Schilling
    Tobias Vogt
    Kerstin Blumenstengel
    Miriam Charbel Issa
    Lars-Olof Mügge
    Christoph Kasper
    Roland Kath
    Klaus Höffken
    Journal of Cancer Research and Clinical Oncology, 2003, 129 : 361 - 366
  • [32] Study of dose escalation and sequence switching of administration of the combination of docetaxel and doxorubicin in advanced breast cancer
    Itoh, K
    Sasaki, Y
    Fujii, H
    Minami, H
    Ohtsu, T
    Wakita, H
    Igarashi, T
    Watanabe, Y
    Onozawa, Y
    Kashimura, M
    Ohashi, Y
    CLINICAL CANCER RESEARCH, 2000, 6 (10) : 4082 - 4090
  • [33] Double high-dose chemotherapy with adriamycin, paclitaxel, cyclophosphamide, and thiotepa followed by autologous peripheral blood stem cell transplantation in women with metastatic breast cancer
    Sayer, HG
    Schilling, K
    Vogt, T
    Blumenstengel, K
    Issa, MC
    Mügge, LO
    Kasper, C
    Kath, R
    Höffken, K
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2003, 129 (06) : 361 - 366
  • [34] Phase I dose-escalation study of afatinib, an ErbB family blocker, plus docetaxel in patients with advanced cancer
    Marshall, John
    Shapiro, Geoffrey I.
    Uttenreuther-Fischer, Martina
    Ould-Kaci, Mahmoud
    Stopfer, Peter
    Gordon, Michael S.
    FUTURE ONCOLOGY, 2013, 9 (02) : 271 - 281
  • [35] A phase I/II dose-escalation study of exisulind and docetaxel in patients with hormone-refractory prostate cancer
    Ryan, CW
    Stadler, WM
    Vogelzang, NJ
    BJU INTERNATIONAL, 2005, 95 (07) : 963 - 968
  • [36] High-dose thiotepa, etoposide and carboplatin as conditioning regimen for autologous stem cell transplantation in patients with high-risk non-Hodgkin lymphoma
    Franca Falzetti
    Mauro Di Ianni
    Stelvio Ballanti
    Giuseppe Iodice
    Antonia Reale
    Olivia Minelli
    Gabriella Serio
    Massimo F. Martelli
    Franco Dammacco
    Angelo Vacca
    Roberto Ria
    Clinical and Experimental Medicine, 2012, 12 : 165 - 171
  • [37] A dose escalation study of docetaxel and oxaliplatin combination in patients with metastatic breast and non-small cell lung cancer
    Kouroussis, C
    Agelaki, S
    Mavroudis, D
    Kakolyris, S
    Androulakis, N
    Kalbakis, K
    Souglakos, J
    Mallas, K
    Bozionelou, V
    Pallis, A
    Adamtziki, H
    Georgoulias, V
    ANTICANCER RESEARCH, 2003, 23 (1B) : 785 - 791
  • [38] Preoperative dose-dense sequential chemotherapy of epirubicin/cyclophosphamide followed by docetaxel/capecitabine in patients with breast cancer.
    Natoli, C.
    Cianchetti, E.
    Ficorella, C.
    Angelucci, D.
    Grossi, S.
    Noccioli, P.
    Ricevuto, E.
    Grassadonia, A.
    Zilli, M.
    Di Giacobbe, A.
    Rispoli, A., I
    Tinari, N.
    Iacobelli, S.
    BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S150 - S150
  • [39] Minimal toxicity and mortality in high-risk breast cancer patients receiving high-dose cyclophosphamide, thiotepa, and carboplatin plus autologous marrow stem-cell transplantation and comprehensive supportive care
    Holland, HK
    Dix, SP
    Geller, RB
    Devine, SM
    Heffner, LT
    Connaghan, DG
    Hillyer, CD
    Hughes, LL
    Miller, RL
    Moore, MR
    Winton, EF
    Wingard, JR
    JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (04) : 1156 - 1164
  • [40] HIGH-DOSE THIOTEPA, CARBOPLATIN AND ETOPOSIDE WITH AUTOLOGOUS HEMATOPOIETIC STEM-CELL TRANSPLANTATION FOR PATIENTS WITH RECURRENT MEDULLOBLASTOMA
    Gevorgian, Asmik
    Tolkunova, Polina
    Iukhta, Tatiana
    Kazantsev, Ilya
    Morozova, Elena
    Andreeva, Tatiana
    Kozlov, Andrew
    Safonova, Svetlana
    Punanov, Yury
    Zubarovskaya, Ludmila
    Zheludkova, Olga
    Afanasyev, Boris
    NEURO-ONCOLOGY, 2018, 20 : 121 - 121
12345